Thomas S. Ebert
Impact in
- Immunology top 2%
- interferon and immune responses
- Immune Response and Inflammation
- IL-33, ST2, and ILC Pathways
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid
Papers in
- Immunology 10
- interferon and immune responses 7
- Immune Response and Inflammation 3
-
- Inflammasome and immune disorders 6
- CRISPR and Genetic Engineering 2
- RNA regulation and disease 2
- Pluripotent Stem Cells Research 1
- Co-authors
- Veit Hornung (14 shared papers)Jonathan Leo Schmid-Burgk (6 shared papers)Tobias Schmidt (4 shared papers)Dhruv Chauhan (3 shared papers)Moritz M. Gaidt (4 shared papers)Francesca A. Rapino (1 shared paper)Thomas Graf (1 shared paper)Matthew A. Cooper (1 shared paper)
- Journals
- Immunity (3 papers)iScience (2 papers)European Journal of Immunology (1 paper)Science Signaling (1 paper)Retrovirology (1 paper)
- Partner nations
- GermanyUnited StatesAustralia
In The Last Decade
Thomas S. Ebert
14 papers receiving 2.1k citations
Thomas S. Ebert's Hit Papers
Peers
Comparison fields: 5 of 90
- Immunology 1.1k
- Nephrology 193
- Molecular Biology 1.6k
- Biological Psychiatry 41
- Infectious Diseases 194
Countries citing papers authored by Thomas S. Ebert
This map shows the geographic impact of Thomas S. Ebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas S. Ebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas S. Ebert more than expected).
Fields of papers citing papers by Thomas S. Ebert
This network shows the impact of papers produced by Thomas S. Ebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas S. Ebert. The network helps show where Thomas S. Ebert may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas S. Ebert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Human Monocytes Engage an Alternative Inflammasome Pathway Hit paper breakdown → | 2016 | 637 |
| 2 | The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING-Cell Death Program Upstream of NLRP3 Hit paper breakdown → | 2017 | 519 |
| 3 | 2015 | 389 | |
| 4 | 2015 | 271 | |
| 5 | 2016 | 128 | |
| 6 | 2016 | 64 | |
| 7 | 2015 | 38 | |
| 8 | 2019 | 28 | |
| 9 | 2024 | 20 | |
| 10 | 2015 | 19 | |
| 11 | 2023 | 11 | |
| 12 | 2024 | 9 | |
| 13 | 2022 | 9 | |
| 14 | 2023 | 6 |
About Thomas S. Ebert
Thomas S. Ebert is a scholar working on Immunology, Molecular Biology, Cardiology and Cardiovascular Medicine, Virology and Physiology, having authored 14 papers that have together received 2.1k indexed citations. Recurring topics across this work include interferon and immune responses (7 papers), Inflammasome and immune disorders (6 papers), Immune Response and Inflammation (3 papers), CRISPR and Genetic Engineering (2 papers), RNA regulation and disease (2 papers), Viral Infections and Immunology Research (2 papers), Animal Genetics and Reproduction (1 paper) and Pluripotent Stem Cells Research (1 paper). The work is most often cited by research in Immunology (1.1k citations), Nephrology (193 citations), Molecular Biology (1.6k citations), Biological Psychiatry (41 citations) and Infectious Diseases (194 citations). Thomas S. Ebert has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include Veit Hornung, Jonathan Leo Schmid-Burgk, Tobias Schmidt, Dhruv Chauhan, Moritz M. Gaidt, Francesca A. Rapino, Thomas Graf, Matthew A. Cooper, Avril A. B. Robertson and Elmar Endl. Their work appears in journals such as Immunity, iScience, European Journal of Immunology, Science Signaling and Retrovirology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.